ArriVent BioPharma (AVBP)
ArriVent BioPharma on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.
6.8M
Short interest
settlement 2026-10-15
2.2
Days to cover
-9.0 days vs prior
52.3%
Short share of volume
2026-11-02
280
Fails to deliver
settlement 2026-10-13
Mon 9 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in AVBP is 6,806,605 shares, down 1,959,641 shares over the last month. Over the last 48 readings it ranged from 3,116,262 shares (15 November 2024) to 8,766,246 shares (15 September 2026). At the reported average volume of 3.1M shares a day that is 2.2 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/avbp" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 6,806,605 | -19.5% | 3,053,489 | 2.23 |
| 2026-09-30 | 8,451,472 | -3.6% | 751,302 | 11.25 |
| 2026-09-15 | 8,766,246 | +0.9% | 495,489 | 17.69 |
| 2026-08-31 | 8,691,715 | +5.6% | 425,433 | 20.43 |
| 2026-08-14 | 8,227,393 | +2.3% | 378,015 | 21.76 |
| 2026-07-31 | 8,046,475 | +5.0% | 578,059 | 13.92 |
| 2026-07-15 | 7,665,375 | +0.5% | 429,478 | 17.85 |
| 2026-06-30 | 7,624,281 | -2.9% | 842,831 | 9.05 |
| 2026-06-15 | 7,847,671 | +1.8% | 598,359 | 13.12 |
| 2026-05-29 | 7,709,676 | +5.6% | 534,531 | 14.42 |
| 2026-05-15 | 7,299,894 | +2.7% | 323,716 | 22.55 |
| 2026-04-30 | 7,109,751 | -7.3% | 497,182 | 14.30 |
| 2026-04-15 | 7,666,061 | -1.3% | 527,179 | 14.54 |
| 2026-03-31 | 7,763,960 | +7.4% | 434,044 | 17.89 |
| 2026-03-13 | 7,228,395 | +3.2% | 775,078 | 9.33 |
| 2026-02-27 | 7,003,796 | -0.6% | 279,146 | 25.09 |
| 2026-02-13 | 7,046,765 | -2.4% | 611,370 | 11.53 |
| 2026-01-30 | 7,216,603 | +0.5% | 432,159 | 16.70 |
| 2026-01-15 | 7,178,615 | +2.8% | 395,082 | 18.17 |
| 2025-12-31 | 6,985,261 | +3.5% | 468,652 | 14.91 |
| 2025-12-15 | 6,747,370 | -7.1% | 457,285 | 14.76 |
| 2025-11-28 | 7,262,061 | +1.3% | 253,289 | 28.67 |
| 2025-11-14 | 7,169,047 | +3.5% | 368,864 | 19.44 |
| 2025-10-31 | 6,927,026 | -1.9% | 305,810 | 22.65 |
| 2025-10-15 | 7,063,874 | +4.1% | 299,753 | 23.57 |
| 2025-09-30 | 6,783,254 | +2.9% | 396,970 | 17.09 |
| 2025-09-15 | 6,594,695 | -3.0% | 341,765 | 19.30 |
| 2025-08-29 | 6,797,763 | +1.4% | 196,809 | 34.54 |
| 2025-08-15 | 6,701,282 | +10.0% | 348,514 | 19.23 |
| 2025-07-31 | 6,091,463 | +5.1% | 252,562 | 24.12 |
| 2025-07-15 | 5,798,215 | +2.9% | 329,812 | 17.58 |
| 2025-06-30 | 5,632,404 | +12.3% | 566,037 | 9.95 |
| 2025-06-13 | 5,016,199 | -12.4% | 407,476 | 12.31 |
| 2025-05-30 | 5,724,768 | +3.7% | 306,490 | 18.68 |
| 2025-05-15 | 5,522,401 | +2.9% | 153,639 | 35.94 |
| 2025-04-30 | 5,364,764 | +0.1% | 159,070 | 33.73 |
| 2025-04-15 | 5,360,488 | +31.7% | 313,256 | 17.11 |
| 2025-03-31 | 4,070,822 | +10.4% | 206,754 | 19.69 |
| 2025-03-14 | 3,686,680 | -1.2% | 194,942 | 18.91 |
| 2025-02-28 | 3,732,642 | -10.9% | 185,161 | 20.16 |
| 2025-02-14 | 4,189,369 | -2.9% | 151,512 | 27.65 |
| 2025-01-31 | 4,315,159 | +8.9% | 143,204 | 30.13 |
| 2025-01-15 | 3,961,184 | +3.8% | 137,001 | 28.91 |
| 2024-12-31 | 3,814,774 | +13.1% | 170,351 | 22.39 |
| 2024-12-13 | 3,372,664 | +1.9% | 121,534 | 27.75 |
| 2024-11-29 | 3,309,151 | +6.2% | 171,325 | 19.32 |
| 2024-11-15 | 3,116,262 | -11.8% | 166,972 | 18.66 |
| 2024-10-31 | 3,535,281 | +3.8% | 126,645 | 27.91 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of AVBP volume is 52.3%, down 4.4 points over the last five sessions. Over the last 30 readings it ranged from 14.7% (27 October 2026) to 86.6% (14 October 2026). The latest reading is 6.5 points below the 30-session average of 58.7%, on 401K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 209K | 401K | 52.3% | 1,981 |
| 2026-10-30 | 171K | 326K | 52.4% | 241 |
| 2026-10-29 | 85K | 240K | 35.5% | 0 |
| 2026-10-28 | 172K | 390K | 44.0% | 0 |
| 2026-10-27 | 96K | 654K | 14.7% | 13,261 |
| 2026-10-26 | 1.4M | 2.5M | 56.6% | 26,744 |
| 2026-10-23 | 666K | 1.7M | 39.0% | 192 |
| 2026-10-22 | 148K | 338K | 43.7% | 0 |
| 2026-10-21 | 412K | 747K | 55.2% | 0 |
| 2026-10-20 | 169K | 296K | 57.0% | 0 |
| 2026-10-19 | 229K | 354K | 64.8% | 0 |
| 2026-10-16 | 416K | 485K | 85.8% | 0 |
| 2026-10-15 | 160K | 283K | 56.4% | 0 |
| 2026-10-14 | 620K | 716K | 86.6% | 0 |
| 2026-10-13 | 665K | 1.0M | 66.0% | 0 |
| 2026-10-12 | 483K | 599K | 80.7% | 4 |
| 2026-10-09 | 593K | 815K | 72.7% | 1,192 |
| 2026-10-08 | 713K | 951K | 74.9% | 0 |
| 2026-10-07 | 1.4M | 2.0M | 72.8% | 63,820 |
| 2026-10-06 | 4.7M | 9.0M | 51.9% | 283,290 |
| 2026-10-05 | 96K | 141K | 68.2% | 0 |
| 2026-10-02 | 143K | 173K | 82.7% | 0 |
| 2026-10-01 | 88K | 245K | 36.1% | 0 |
| 2026-09-30 | 168K | 312K | 53.9% | 0 |
| 2026-09-29 | 193K | 350K | 55.3% | 4 |
| 2026-09-28 | 81K | 267K | 30.2% | 0 |
| 2026-09-25 | 239K | 299K | 79.9% | 0 |
| 2026-09-24 | 233K | 282K | 82.7% | 0 |
| 2026-09-23 | 315K | 576K | 54.7% | 0 |
| 2026-09-22 | 69K | 127K | 54.4% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in AVBP is 280 shares, up 200 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (14 September 2026) to 206,555 shares (7 October 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 280 | $16.46 | $5K |
| 2026-10-09 | 80 | $16.71 | $1K |
| 2026-10-07 | 206,555 | $15.09 | $3.1M |
| 2026-09-24 | 1,560 | $30.30 | $47K |
| 2026-09-23 | 2,033 | $30.32 | $62K |
| 2026-09-22 | 47 | $29.74 | $1K |
| 2026-09-14 | 1 | $29.00 | $29 |
| 2026-09-10 | 209 | $29.79 | $6K |
| 2026-09-09 | 3,773 | $30.28 | $114K |
| 2026-09-02 | 58 | $30.15 | $2K |
| 2026-09-01 | 8 | $30.05 | $240 |
| 2026-08-31 | 663 | $30.17 | $20K |
| 2026-08-28 | 98 | $31.00 | $3K |
| 2026-08-27 | 173 | $31.14 | $5K |
| 2026-08-26 | 20 | $31.35 | $627 |
| 2026-08-17 | 202 | $29.51 | $6K |
| 2026-08-13 | 99 | $31.46 | $3K |
| 2026-08-12 | 3,049 | $31.39 | $96K |
| 2026-08-05 | 1,807 | $31.49 | $57K |
| 2026-08-03 | 64 | $29.82 | $2K |
| 2026-07-21 | 542 | $28.22 | $15K |
| 2026-07-17 | 496 | $32.76 | $16K |
| 2026-07-16 | 1,343 | $32.95 | $44K |
| 2026-07-15 | 35 | $32.54 | $1K |
| 2026-07-14 | 846 | $33.64 | $28K |
| 2026-07-09 | 2,811 | $33.40 | $94K |
| 2026-06-30 | 517 | $34.37 | $18K |
| 2026-06-29 | 134,539 | $34.00 | $4.6M |
| 2026-06-26 | 1,157 | $33.83 | $39K |
| 2026-06-24 | 27,809 | $33.74 | $938K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for AVBP in the last 90 days. The most recent filings are listed below. Latest filing: LaChapelle Robin (Chief Operating Officer) on 2026-10-30.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-30 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 18K | $6.24 | $110K | 176K |
| 2026-10-30 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 2K | $2.28 | $4K | 159K |
| 2026-10-30 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 5K | $2.28 | $10K | 157K |
| 2026-10-30 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 410 | $2.28 | $935 | 152K |
| 2026-10-30 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 16K | $3.65 | $59K | 152K |
| 2025-12-10 | HHLR ADVISORS, LTD. | TenPercentOwner | Sell | 556K | $23.37 | $13.0M | 3.9M |
| 2025-12-10 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10% owner | Sell | 556K | $23.37 | $13.0M | 3.9M |
| 2025-07-11 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 7K | $2.28 | $15K | 136K |
| 2025-07-11 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 3K | $2.28 | $6K | 129K |
| 2025-07-11 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 2K | $2.28 | $5K | 127K |
| 2024-09-19 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 3K | $2.28 | $7K | 103K |
| 2024-09-19 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 3K | $6.24 | $17K | 100K |
| 2024-09-19 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 7K | $2.28 | $16K | 110K |
| 2024-09-19 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 12K | $3.65 | $45K | 125K |
| 2024-09-19 | LaChapelle Robin | Chief Operating Officer | Exercise or conversion | 2K | $2.28 | $6K | 112K |
| 2024-01-30 | GORDON CARL L | Director, 10% owner | Buy | 222K | $18.00 | $4.0M | 1.5M |
| 2024-01-30 | GORDON CARL L | Director, 10% owner | Conversion | 470K | price not stated in the filing | not stated | 1.3M |
| 2024-01-30 | GORDON CARL L | Director, 10% owner | Conversion | 822K | price not stated in the filing | not stated | 822K |
| 2024-01-30 | HEALY JAMES | Director | Buy | 444K | $18.00 | $8.0M | 1.7M |
| 2024-01-30 | HEALY JAMES | Director | Conversion | 1.3M | price not stated in the filing | not stated | 1.3M |
| 2024-01-30 | GORDON CARL L | Director,TenPercentOwner | Conversion | 822K | price not stated in the filing | not stated | 822K |
| 2024-01-30 | GORDON CARL L | Director,TenPercentOwner | Buy | 222K | $18.00 | $4.0M | 1.5M |
| 2024-01-30 | GORDON CARL L | Director,TenPercentOwner | Conversion | 470K | price not stated in the filing | not stated | 1.3M |
| 2024-01-30 | OrbiMed Asia GP IV, L.P. | Director,TenPercentOwner | Conversion | 822K | price not stated in the filing | not stated | 822K |
| 2024-01-30 | OrbiMed Asia GP IV, L.P. | Director,TenPercentOwner | Conversion | 470K | price not stated in the filing | not stated | 1.3M |
| 2024-01-30 | OrbiMed Asia GP IV, L.P. | Director,TenPercentOwner | Buy | 222K | $18.00 | $4.0M | 1.5M |
| 2024-01-30 | HHLR ADVISORS, LTD. | TenPercentOwner | Conversion | 3.6M | price not stated in the filing | not stated | 3.6M |
| 2024-01-30 | HHLR ADVISORS, LTD. | TenPercentOwner | Buy | 556K | $18.00 | $10.0M | 4.5M |
| 2024-01-30 | HHLR ADVISORS, LTD. | TenPercentOwner | Conversion | 313K | price not stated in the filing | not stated | 3.9M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON10 holders report 5% or more of AVBP in their latest filing, 1 on Schedule 13D (active intent). The largest reported stake is INFINITUM ASSET MANAGEMENT, LLC at 9.9% of the class (4,123,923 shares), filed 2026-02-17 for an event on 2025-12-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-13 | 13G | Vivo Opportunity, LLCother entity | 2.5M | 5.0% | 2026-10-06 |
| 2026-10-13 | 13G | Vivo Opportunity Fund Holdings, L.P.partnership | 1.5M | 3.1% | 2026-10-06 |
| 2026-10-13 | 13G | Vivo Opportunity Co-Invest (Cycle 3), L.P.partnership | 782K | 1.6% | 2026-10-06 |
| 2026-10-13 | 13G | Vivo Opportunity Cayman, LLCother entity | 153K | 0.3% | 2026-10-06 |
| 2026-10-13 | 13G | Vivo Opportunity Co-Invest, L.P.partnership | 177K | 0.3% | 2026-10-06 |
| 2026-10-13 | 13G | Vivo Opportunity Cayman Fund, L.P.partnership | 153K | 0.3% | 2026-10-06 |
| 2026-10-08 | 13D/Ano. 2 | ORBIMED ADVISORS LLCinvestment adviser | 2.9M | 5.8% | 2026-10-06 |
| 2026-10-08 | 13D/Ano. 2 | OrbiMed Advisors IV Limitedcorporation | 1.4M | 2.9% | 2026-10-06 |
| 2026-10-08 | 13D/Ano. 2 | OrbiMed Asia GP IV, L.P.partnership | 1.4M | 2.9% | 2026-10-06 |
| 2026-10-08 | 13D/Ano. 2 | OrbiMed Capital GP VIII LLCother entity | 1.4M | 2.9% | 2026-10-06 |
| 2026-07-27 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 3.2M | 6.8% | 2026-06-30 |
| 2026-05-06 | 13G/Ano. 2 | FMR LLCparent holding company | 3.0M | 6.8% | 2026-03-31 |
| 2026-05-06 | 13G/Ano. 2 | Abigail P. Johnsonindividual | 3.0M | 6.8% | 2026-03-31 |
| 2026-03-05 | 13G/Ano. 1 | Dr. James I. Healy ("Healy")individual | 1.7M | 4.1% | 2025-12-31 |
| 2026-03-05 | 13G/Ano. 1 | Sofinnova Venture Partners XI, L.P. ("SVP XI")partnership | 1.7M | 4.1% | 2025-12-31 |
| 2026-03-05 | 13G/Ano. 1 | Sofinnova Management XI, L.P. ("SM XI LP")partnership | 1.7M | 4.1% | 2025-12-31 |
| 2026-03-05 | 13G/Ano. 1 | Sofinnova Management XI, L.L.C. ("SM XI LLC")other entity | 1.7M | 4.1% | 2025-12-31 |
| 2026-03-05 | 13G/Ano. 1 | Dr. Maha Katabi ("Katabi")individual | 1.7M | 4.1% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | INFINITUM ASSET MANAGEMENT, LLCinvestment adviser | 4.1M | 9.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Infinitum Partners GP, LLCpartnership | 4.1M | 9.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Infinitum Cayman Master, Ltd.partnership | 4.1M | 9.9% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Hillhouse Investment Management, Ltd.investment adviser | 3.9M | 9.5% | 2025-12-31 |
| 2026-01-30 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 1.9M | 4.5% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 1 | Ting Jiaindividual | 2.0M | 4.9% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Octagon Capital Advisors LPinvestment adviser, partnership | 2.0M | 4.9% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Octagon Private Opportunities Fund LPpartnership, other entity | 800K | 2.0% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Octagon Investments Master Fund LPpartnership, other entity | 777K | 1.9% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Octagon Special Opportunities Fund LP - Series 4partnership, other entity | 394K | 1.0% | 2025-09-30 |
| 2025-10-15 | 13G | HBM Healthcare Investments (Cayman) Ltd.corporation | 2.2M | 5.4% | 2025-10-08 |
13F holders
Tracked managers holding AVBP at their latest 13F. JSON6 of the 30 tracked managers held AVBP at their latest 13F, $73.4M in total at quarter-end prices. D. E. Shaw & Co. is the largest at $30.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| D. E. Shaw & Co. | 2026-06-30 | 872K | $30.3M | 0.01% | +503K |
| Point72 Asset Management | 2026-06-30 | 567K | $19.7M | 0.02% | -181K |
| Millennium Management | 2026-06-30 | 439K | $15.2M | 0.01% | +13K |
| Citadel Advisors | 2026-06-30 | 157K | $5.4M | 0.00% | -9K |
| Two Sigma Investments | 2026-06-30 | 58K | $2.0M | 0.00% | +9K |
| AQR Capital Management | 2026-06-30 | 22K | $748K | 0.00% | +6K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
ArriVent BioPharma in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows ArriVent BioPharma (AVBP), SEC CIK 1868279, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-13.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-30.JSON and CSV
- Company record
- EDGAR filing index for CIK 1868279Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
- SYRESpyre Therapeutics
- SYYSysco
- TAT&T
- TAPMolson Coors
- TCOMTrip.com Group
- TDToronto-Dominion Bank
- TDGTransDigm Group
- TDYTeledyne Technologies
Datasets
Frequently Asked Questions
How much of AVBP is sold short?
6,806,605 shares were held short at the 2026-10-15 settlement, 2.2 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is AVBP's daily short volume?
On 2026-11-02, 209,247 of the 400,510 AVBP shares reported to FINRA were sold short, 52.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does AVBP have fails to deliver?
The SEC's latest file shows 280 AVBP shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are AVBP insiders buying or selling?
No open-market insider trades were reported for AVBP in the last 90 days. The most recent filings are listed below. Latest filing: LaChapelle Robin (Chief Operating Officer) on 2026-10-30.
Who owns 5% or more of AVBP?
10 holders report 5% or more of AVBP in their latest filing, 1 on Schedule 13D (active intent). The largest reported stake is INFINITUM ASSET MANAGEMENT, LLC at 9.9% of the class (4,123,923 shares), filed 2026-02-17 for an event on 2025-12-31.
Which tracked 13F managers own AVBP?
6 of the 30 tracked 13F managers held AVBP shares at their latest filing, $73.4M in all. The largest: D. E. Shaw & Co. (872K shares, $30.3M), Steve Cohen's Point72 Asset Management (567K shares, $19.7M), Izzy Englander's Millennium Management (439K shares, $15.2M), Ken Griffin's Citadel Advisors (157K shares, $5.4M), Two Sigma Investments (58K shares, $2.0M), Cliff Asness's AQR Capital Management (22K shares, $748K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.